Proteome analysis of platelets in Essential Thrombocythemia couples metabolism to platelet reactivity
Carreno, X. G.; Smits, S.; Lasso, A. E.; Samiotaki, M.; Navarro, V. C.; Iborra, F. J.; Rantanen, F.; Larran, A. A.; Figueras, A. A.; Bellosillo, B.; Marin, A. J. S.; Gutierrez, V. G.; Dekkers, D.; Demmers, J.; Marin, F. F.; Boluda, J. C. H.; Matsakas, A.; Cuesta, C. M. B.; Vandenberghe, P.; Papadopoulos, P.
Show abstract
Platelets are key players in hemostasis and thrombosis. Essential thrombocythemia (ET) is a myeloproliferative neoplasm (MPN) in which the JAK2 V617F, MPL W515K/L, and CALR mutations determine differences in clinical phenotype, in particular the thrombotic risk and the risk of myelofibrosis. Here, we examined the proteome of platelets in ET by mass spectrometry (MS) in combination with functional assays to gain insights into platelet activation in ET. MS analysis revealed a different proteome in ET platelets with stoichiometric differences in mitochondrial proteins compared with normal platelets. The tricarboxylic acid cycle enzymes (TCA) were in general downregulated in ET platelets while glycolysis enzymes were upregulated changing modes in energy production. Acetyl salicylic acid (ASA) treatment increased levels of TCA enzymes in controls and restored them only partially in JAK2 V617F platelets. Interestingly, membrane CD36 was higher in CALR Type1 implicating lipid transport and fatty acid oxidation in platelet lifespan. Aggregation levels specifically in JAK2 V617F platelets were similar or lower to healthy controls while activation markers i.e. CD62P were higher in untreated CALR Type2 than controls and the rest of ET. In summary, analysis of platelet proteome in ET implicates mitochondrial activity in platelet activation and also identified differences between JAK2 V617F and CALR patients. Our study suggests that metabolic finetuning can be critical in the control of platelet reactivity. Key pointsO_LITCA cycle enzymes are downregulated in ET platelets. ASA treatment leads to a partial correction in JAK2 V617F platelets. C_LIO_LICD62P expression and aggregation levels of untreated CALR Type2 are higher than JAK2 V617F platelets. C_LI Visual Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=79 SRC="FIGDIR/small/25323560v1_ufig1.gif" ALT="Figure 1"> View larger version (11K): org.highwire.dtl.DTLVardef@1e2e8ccorg.highwire.dtl.DTLVardef@21c3b0org.highwire.dtl.DTLVardef@b69467org.highwire.dtl.DTLVardef@c907ff_HPS_FORMAT_FIGEXP M_FIG C_FIG
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Proteome and functional decline as platelets age in the circulation 95%
- Utility of thromboelastography with platelet mapping (TEG-PM) for monitoring platelet transfusion in qualitative platelet disorders 95%
- Quantitative super-resolution imaging of platelet degranulation reveals differential release of VWF and VWF propeptide from alpha-granules 94%
Similar papers in this journal
- Sickle red blood cell derived extracellular vesicles activate endothelial cells and enhance sickle red cell adhesion mediated by von Willebrand factor 94%
- Platelet dysfunction in immune thrombocytopenia: finding clinical subsets with platelet phenotypes 93%
- Delayed-Phase Thrombocytopenia in Patients of Coronavirus Disease 2019 (COVID-19) 90%
Similar papers in this journal
Similar papers in this journal
- cAMP prevents antibody-mediated thrombus formation in COVID-19 95%
- Temporal in vivo platelet labelling in mice reveals age-dependent receptor expression and conservation of specific mRNAs 94%
- Antithrombotic Efficacy and Bleeding Risks of Vaccine-Induced Immune Thrombotic Thrombocytopenia Treatments 93%
Similar papers in this journal
- Erythropoietin production?by the kidney and the liver in response to severe hypoxia evaluated by Western blotting with deglycosylation 90%
- Nephrotic Syndrome-Associated Hypercoagulopathy is Alleviated by Nuclear Receptor Agonist Therapy with both Pioglitazone and Glucocorticoids 90%
- Prediction of plasma volume and total hemoglobin mass with machine learning 89%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.